treatment goals in refractory mcrc
Published 6 years ago • 994 plays • Length 3:04Download video MP4
Download video MP3
Similar videos
-
7:32
treatment options in refractory mcrc
-
3:21
newly diagnosed mcrc treatment goals
-
3:21
newly diagnosed mcrc treatment goals
-
7:35
use of regorafenib in refractory mcrc
-
3:43
goals of therapy in refractory colorectal cancer
-
4:26
sequencing of therapy in refractory mcrc
-
8:04
first- and second-line treatment for mcrc in specific populations
-
3:33
fruquintinib provides improvement in overall survival for refractory mcrc
-
8:34
relapsed/refractory mcrc: immunotherapy in msi-high tumors
-
3:08
the treatment goals of mcrc
-
4:58
tas-102 in refractory metastatic colorectal cancer
-
37:22
eha 2024 recap: optimizing the relapsed/refractory cll treatment pathway
-
2:39
patients with refractory metastatic colorectal cancer experience survival benefits with fruquintinib
-
4:53
debate: salvage therapy for mcrc? - tas-102 followed by regorafenib
-
2:56
focus4-n: maintenance capecitabine monotherapy in mcrc
-
9:06
debate: is there an optimal treatment for refractory colorectal cancer? - tas-102 or regorafenib
-
8:36
debate: is there an optimal sequence for first-line therapy in mcrc? - yes
-
18:55
emerging treatment options for mcrc patients in the late-line setting